/Bristol-Myers%20Squibb%20Co_%20logo%20on%20building-by%20tatu%20Campelo%20via%20iStock.jpg)
Based in New York, New York, Bristol-Myers Squibb Company (BMY) is a global biopharmaceutical leader focused on discovering, developing, and delivering innovative medicines. With a market cap of $108.2 billion, BMY addresses unmet medical needs across therapeutic areas, including oncology, immunology, and cardiovascular health. The company is scheduled to announce its Q3 earnings before the market opens on Thursday, Oct. 31.
Ahead of the event, analysts expect BMY to report a profit of $1.52 per share, down 24% from $2 in the year-ago quarter. The company has consistently beaten Wall Street's earnings estimates in the last four quarters.